HGH Frag 176-191
Limited human dataThe supposed fat-burning end of growth hormone, isolated and sold freely, even though the upgraded version already failed in human trials.
What it is
HGH fragment 176-191 is the last 16 amino acids of human growth hormone, the region tied to burning fat. It was identified in the 1990s. The version people can actually buy is this unmodified fragment; a modified, more stable cousin called AOD9604 went through formal drug development separately.
How it works
The idea is elegant selectivity. Where full growth hormone builds organs, raises insulin resistance, and drives other effects, this fragment is supposed to focus on the fat-burning action alone, stimulating the breakdown of stored triglycerides in fat tissue without the broader hormone baggage.
What people report
- ✦Lab and animal work support a real fat-burning (lipolytic) effect
- ✦The selectivity concept, fat loss without full GH side effects, is mechanistically sound
- ✦Cheap, with usually mild reported side effects
- ✦A subset of community users report noticeable fat loss during cut cycles
Typical use
Typically injected daily during fat-loss or cutting phases for several weeks, mirroring the parent drug's unreached target. No validated cycle exists.
Dosing reference
No approved dose. The most rigorous human data comes from the modified cousin AOD9604, which cleared early safety but failed its phase 2b weight-loss trial. The unmodified fragment people buy has even less human data. Verify accordingly.
Reference only — not a recommendation. Verify via primary sources.
Watch for
The formal human evidence does not back the marketing strength. Community reports split roughly 50/50 between 'works' and 'does nothing,' the response distribution of something not reliably doing what it claims. Older work even hints this region can raise blood sugar, complicating the clean fat-loss story.
Notes
Real research origins, real biology, real clinical disappointment. The upgraded version was tested honestly and failed to meet its endpoints.
Educational content — not medical advice.